This is unpublished

Anna B.

Physician & Research Faculty
Associate Professor, Division of Hematology and Oncology, University of Washington
Associate Professor, Clinical Research Division, Fred Hutchinson Cancer Center
Sites of Practice
Fred Hutchinson Cancer Center - South Lake Union

Education, training, board certifications

  • M.D., Brown University
  • Residency, University of Chicago
  • Fellowship, UW/Fred Hutch
  • Internal Medicine, American Board of Internal Medicine
  • Oncology, American Board of Internal Medicine
  • Hematology, American Board of Internal Medicine

Clinical expertise

  • Hematologic malignancies
  • Acute myeloid leukemia
  • Blood disorders
  • Polycythemia vera
  • Myelofibrosis
  • Essential thrombocytosis
  • Myelodysplastic syndrome
  • Myeloproliferative disorder



Clinical and/or research interests

Dr. Anna Halpern's clinical interests include myeloproliferative neoplasms (polycythemia vera, essential thrombocythemia, myelofibrosis), myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML).

Dr. Halpern conducts clinical and outcomes research in myieloproliferatiave neoplasms, MDS and AML. Her overarching research aim is to improve the outcomes of adults with hematologic malignancies via the development and testing of evidence-based, rational therapies that are tailored to individual patients. To this end, she designs and conducts clinical trials testing novel care concepts for patients with myeloid neoplasms and uses large databases to study systems-issues on a broader scale, such as risk factors for toxicities from treatment. She is currently the Principal Investigator for multiple clinical trials for advanced myeloid neoplasms.